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Summary
Background: Although sleep is an important process
essential for life, its regulation is poorly understood.
The recently developed Drosophila model for sleep pro-
vides a powerful system to genetically and phar-
macologically identify molecules that regulate sleep.
Serotonin is an important neurotransmitter known to
affect many behaviors, but its role in sleep remains
controversial.
Results: We generated or obtained flies with genetically
altered expression of each of threeDrosophila serotonin
receptor subtypes (d5-HT1A, d5-HT1B, and d5-HT2)
and assayed them for baseline sleep phenotypes. The
data indicated a sleep-regulating role for the d5-HT1A
receptor. d5-HT1A mutant flies had short and frag-
mented sleep, which was rescued by expressing the
receptor in adult mushroom bodies, a structure associ-
ated with learning and memory in Drosophila. Neither
the d5-HT2 receptor nor the d5-HT1B receptor, which
was previously implicated in circadian regulation, had
any effect on baseline sleep, indicating that serotonin
affects sleep and circadian rhythms through distinct
receptors. Elevating serotonin levels, either pharmaco-
logically or genetically, enhanced sleep in wild-type
flies. In addition, serotonin promoted sleep in some
short-sleep mutants, suggesting that it can compensate
for some sleep deficits.
Conclusions: These data show that serotonin promotes
baseline sleep in Drosophila. They also link the regula-
tion of sleep behavior by serotonin to a specific receptor
in a distinct region of the fly brain.
Introduction
Sleep is an essential part of animal physiology, with hu-
mans spending more than one-third of their lives in the
sleep state [1, 2]. Sleep is also a complex process influ-
enced by both genetic and environmental components.
Despite the clear necessity for sleep and the extensive
investigation of this process, the brain structures that
drive sleep, the cellular mechanisms involved in sleep
regulation, and the function of sleep are still unclear.
Multiple approaches, including activity monitoring,
arousal threshold measurements, rebound sleep follow-
ing sleep deprivation, responsiveness to sleep-altering
drugs, and electrophysiological studies, indicate that
rest inDrosophila shares features with mammalian sleep
*Correspondence: amita@mail.med.upenn.edu[3–5]. Studies in flies by both a candidate gene approach
and large-scale genetic screens have identified several
genes involved in sleep regulation, including the
cAMP-dependent protein kinase (PKA), cAMP response
element binding protein (CREB), a potassium channel,
Shaker, and the dopamine transporter fumin [6–8].
A study in mammals confirmed a connection between
CREB activity and the control of the sleep/wake cycle,
suggesting that mechanisms of sleep regulation are
conserved from flies to mammals [9].
Serotonin (5-hydroxytryptamine, 5-HT) is a neuro-
transmitter widely distributed in the central and periph-
eral nervous systems of both mammals and insects [10,
11]. The idea that serotonin is involved in the regulation
of sleep-wake cycles was proposed some time ago [12],
but its role remains unclear [13, 14]. Reducing serotonin
levels through pharmacological treatment or surgical
ablation of serotonergic cells causes insomnia, suggest-
ing that serotonin promotes sleep [15]. On the other
hand, neuronal activity of serotonergic neurons and
the timing of serotonin release suggest that it is associ-
ated with the waking state [16]. Knockout mouse models
for several serotonin receptor subtypes support an as-
sociation between serotonin and sleep but have not
clarified the mechanistic link. Overall, the results of
many different approaches support the idea that seroto-
nin suppresses rapid eye movement (REM) sleep [14,
17–19]; however, the effects on non-REM (NREM) sleep
are debatable [13, 20].
In Drosophila, serotonergic neurons send projections
to most brain regions [11, 21]. Four serotonin receptors
have been identified in the Drosophila genome, d5-
HT1A, d5-HT1B, d5-HT2, and d5-HT7 [22–24]. They are
all G protein-coupled receptors and share considerable
sequence similarity with their mammalian homologs.
Conserved effects of serotonin on the regulation of com-
plex behaviors in flies and mammals were demonstrated
in fly models of addiction, aggression, and circadian en-
trainment [25–27]. We considered the possibility that
serotonin might affect sleep/arousal regulation in Dro-
sophila. Therefore, we tested the baseline sleep pheno-
types of flies with genetically modified expression of
three Drosophila serotonin receptors. Flies carrying
a truncated d5-HT1A receptor had decreased sleep
amount and poor consolidation, while flies with reduced
levels of the other two receptors, d5-HT1B and d5-HT2,
showed no baseline sleep abnormalities. The short and
fragmented sleep phenotype of the d5-HT1A receptor
mutant was rescued by a transgene of d5-HT1A
expressed specifically in adult mushroom bodies. In
addition, elevating serotonin levels pharmacologically
or genetically promoted baseline sleep in wild-type flies.
A serotonin precursor also enhanced sleep in some
known sleep mutants but failed to have effects when
chemical neurotransmission was blocked in serotoner-
gic cells, indicating that increased extracellular seroto-
nin is required to promote sleep. We propose that the
serotonin system is important for baseline sleep control
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receptor in adult mushroom bodies.
Results
Baseline Sleep Phenotypes in Flies with Modified
Levels of Drosophila Serotonin Receptors
We collected or generated loss-of-function mutants of
the Drosophila homologs of the mammalian 5-HT1 and
5-HT2 classes of receptors, which have been implicated
in sleep regulation [14, 17, 19, 28, 29]. Baseline sleep
phenotypes were studied under alternating light-dark
conditions in 7- to 10-day-old female flies bearing muta-
tions in the following genes: d5-HT1A, d5-HT1B (both of
which are Drosophila homologs of the mammalian
5-HT1A receptor), and d5-HT2. Total daily sleep and
sleep bout length were used to describe overall sleep
and sleep consolidation [30, 31].
We previously studied the d5-HT1B receptor and
demonstrated that it functions in the circadian response
to light [27]. To assay the effect of d5-HT1B on sleep, we
expressed UAS-d5-HT1B and UAS-d5-HT1BRNAi
transgenes in different cell types by means of a variety
of drivers including elav-Gal4 for panneuronal expres-
sion, tim-Gal4 for expression in clock cells, Ddc-Gal4
for expression in serotonin- and dopamine-producing
cells, and d5-HT1B-Gal4 for expression in locations
that express endogenous receptor. The effects of the
UAS-d5-HT1B and UAS-d5-HT1BRNAi transgenes on
increasing or decreasing, respectively, the levels of
d5-HT1B protein and on circadian photosensitivity
were shown previously [27]. Daily sleep was compared
between flies overexpressing d5-HT1B and those that
had d5-HT1B expression knocked down through RNAi.
Regardless of the Gal4 driver used to express the UAS
transgenes or of the level of d5-HT1B receptor in a given
region of the brain, no significant differences were found
in either the total amount of sleep or in sleep consolida-
tion measured as the average length of sleep bouts
(Figure 1A, data not shown). These data suggest that
the d5-HT1B receptor is not involved in the regulation
of baseline sleep in Drosophila.
The mammalian 5-HT2 receptor is implicated in sev-
eral psychopathological conditions in humans, includ-
ing schizophrenia and eating disorder [32–34]. Pharma-
cological studies in mammals suggest that serotonin
acts on 5-HT2 receptors in the thalamus to produce an
arousing effect [35]. On the other hand, mouse knock-
outs of 5-HT2A and 5-HT2C have mildly reduced
NREM sleep [28, 29]. Analysis of the Drosophila homo-
log of the 5-HT2 receptor is limited [24, 36], in part due
to the lack of loss-of-function mutants.
We obtained a fly line from the Exelixis collection car-
rying a piggybac insertion in the third intron of the d5-
HT2 gene [37, 38] (see Figure S1 in the Supplemental
Data available with this article online). Due to the pres-
ence of dual splice donor sites in this P element, the
d5-HT2 transcript is disrupted, producing a loss-
of-function allele. Specifically, the expression of three
exons downstream of the insertion, which encode
essential intracellular and transmembrane domains, is
affected (Figure S1). Sleep analysis indicated that nei-
ther total sleep nor sleep bout length was significantly
different between flies with reduced d5-HT2 levels andcontrols (Figure 1B), suggesting that this receptor sub-
type is not involved in the regulation of fly baseline sleep.
The d5-HT1A receptor, like the d5-HT1B receptor, is
a homolog of the mammalian 5-HT1A receptor. It shares
more than 80% homology with d5-HT1B and is located
in close cytogenetic proximity. To generate a loss-of-
function mutant of d5-HT1A, we obtained a fly line with
a P element insertion 2.5 kb downstream of its coding
region [39]. We then carried out crosses to excise this
element and screened w500 independent P excision
lines. One P excision event generated an imprecise exci-
sion deleting more than 5 kb of genomic sequence in-
cluding the 30 coding region of d5-HT1A. In a baseline
sleep assay, flies carrying deletions in d5-HT1A showed
significantly reduced sleep and sleep bout length as
compared to control flies from a precise excision line
that does not affect the d5-HT1A receptor (Figure 1C).
The analysis of flies with modified expression levels of
three Drosophila serotonin receptor subtypes sug-
gested that d5-HT1A is a specific receptor subtype
that regulates baseline sleep in flies. We carried out
detailed molecular and behavioral studies focused on
the d5-HT1A mutant flies in the following experiments.
Characterization of the Lesion in d5-HT1A Mutants
To confirm that we had generated a loss-of-function mu-
tant of d5-HT1A, we characterized the deletion in the P
excision line by genomic PCR and RT-PCR (Figures 2A
and 2B). Although 5-HT1A transcripts were still ex-
pressed in these flies, the last two exons, which encode
the sixth and seventh transmembrane domains, the
C-terminal end, and a part of the third intracellular
loop, were deleted (Figure 2B). In addition, the transcript
produced by the neighboring gene CG15117, which en-
codes a putative metabolic enzyme, was also affected
(Figure 2A, see Discussion).
Since flies carrying the deletion were capable of pro-
ducing a truncated form of the receptor, we cloned
and tested the full-length and truncated receptors in
an S2 cell culture system. The truncated receptor was
expressed diffusely in the cytoplasm, in contrast to the
full-length receptor that localized largely to the cell sur-
face (Figure 2C). In response to serotonin, the full-length
receptor on the cell surface was internalized and formed
clusters while the truncated receptor showed no
changes in its cytoplasmic distribution (Figure 2C).
Thus, consistent with previous functional studies of
C-terminal truncated G protein-coupled receptors
[40, 41], the lesion in the d5-HT1A gene leads to altered
subcellular localization and loss of the response to sero-
tonin. We surmise that flies carrying the truncated re-
ceptor are loss-of-function mutants of d5-HT1A.
Phenotypic Analysis of d5-HT1A Mutant Flies
The d5-HT1A mutant did not have visible defects in body
and brain development or in locomotion. In circadian
behavioral assays, d5-HT1A mutant flies showed normal
free-running rhythms, although the strength of the
rhythm was reduced (Figure 3A). We infer that the re-
duced rhythm strength was due to increased nighttime
activity resulting from the decrease in sleep. Unlike flies
with reduced levels of the d5-HT1B receptor [27], the
d5-HT1A mutants did not show increased circadian
photosensitivity as measured by light-induced phase
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Loss-of-Function Mutants of Three Drosoph-
ila Serotonin Receptors
(A) Female flies with modified levels of the d5-
HT1B receptor have similar baseline sleep
levels and sleep bout lengths as control flies.
Average daily sleep and average sleep bout
length of flies expressing UAS-d5-HT1B or
UAS-d5-HT1BRNAi under the control of d5-
HT1B-Gal4 (1B-Gal4) or tim-Gal4 (TG) are
shown.
(B) Daily sleep and bout length in flies with re-
duced levels of the d5-HT2 receptor (5-
HT2RB) are similar to those of background
control flies (w1118).
(C) Flies with a lesion in the d5-HT1A receptor
show a reduction in both daily sleep and
sleep consolidation. d5-HT1A mutant flies
(1At/t) were generated through the imprecise
excision of a P element. A simultaneously
generated fly line that contained a precise ex-
cision, and thus did not have a lesion in d5-
HT1A, served as the background control
(1A+/+). **p < 0.01, by Student’s t test; the
number of flies tested for each data set was
w30, from two independent experiments.
Error bars represent SEM.shifts in the late night, suggesting nonredundant func-
tions of these two receptors in the circadian system
(data not shown). Consistent with the lack of a role in cir-
cadian rhythms, transcript levels of d5-HT1A did not
vary at different times of day (data not shown).
We then conducted a detailed sleep analysis of
d5-HT1A mutant flies. Sleep during the light and dark
periods of the day was considered separately for higher
resolution. Precise excision lines that did not affect the
d5-HT1A gene, as well as heterozygous flies carrying
one copy of the deletion, were used as background con-
trols. The circadian profile of activity and sleep indicated
that the onset and offset of activity as well as the distri-
bution of sleep were similar in mutant and control flies
(Figure 3B). However, the d5-HT1A mutant had signifi-
cantly reduced total sleep and sleep bout length, as
well as an increased number of sleep bouts, indicating
that sleep was both reduced and fragmented
(Figure 3B). Note that significant changes were noticed
only for nighttime sleep in females, since they havelimited and poorly consolidated daytime sleep. Although
our studies focused largely on females, the gender of
choice for sleep studies inDrosophila [5, 30], we also ex-
amined sleep in male d5-HT1A mutant flies (Figure S2).
These also had reduced overall sleep relative to their
controls (Figure S2). However, since sleep in Drosophila
is gender dimorphic, with daytime sleep accounting for
a significant proportion of sleep in males [30], the sleep
phenotype in d5-HT1A males was evident during the day
and night.
We also assayed sleep in constant dark conditions,
which typically decrease sleep consolidation. As ex-
pected, when flies were transferred from light-dark
cycles to constant darkness conditions, total sleep
and sleep bout length were reduced, while sleep bout
number increased. At the same time, the d5-HT1A mu-
tant showed significantly larger changes in these pa-
rameters in response to the absence of light-dark cycles
(Figure 3C), suggesting that mechanisms for maintain-
ing sleep stability are impaired in these flies. This was
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the d5-HT1A Gene
(A) Schematic representation of the lesion
generated by imprecise excision of a P inser-
tion in the d5-HT1A gene. An arrowhead indi-
cates the P element insertion. The stippled
bar represents the extent of the deletion gen-
erated by the imprecise excision. Arrows in-
dicate two sets of primers designed to am-
plify the fifth and eighth exons of d5-HT1A
transcripts. The blocks represent exons.
(B) Mutant flies express d5-HT1A transcripts
with truncated 30 ends. Total RNA was ex-
tracted from wild-type flies (w1118), three pre-
cise excision lines (PE1, 2, 3), and flies with
a d5-HT1A deletion (1At/1At). PCR reactions
for tubulin transcripts served as controls. Mu-
tant d5-HT1A flies produced d5-HT1A tran-
scripts (indicated by the PCR product of the
fifth exon), which were truncated at the 30
end (indicated by the absence of a PCR prod-
uct of the eighth exon).
(C) The C-terminal truncated d5-HT1A recep-
tor does not respond to serotonin. Represen-
tative projected confocal images of immunostained S2 cells expressing full-length or truncated d5-HT1A receptors are shown. S2 cells tran-
siently transfected with V5 epitope-tagged d5-HT1A receptors were collected after 30 min of mock or serotonin (100 nm) treatment. The cells
were fixed and subjected to immunostaining with an anti-V5 antibody. Full-length receptor was expressed mainly on the cell surface and, in
w30% cells, was internalized after serotonin treatment, while the truncated receptor was diffusely distributed in the cytoplasm and failed to
respond to serotonin.also indicated by their reduced homeostatic response to
sleep deprivation. We deprived the d5-HT1A mutant and
its background control of sleep by subjecting them to
mechanical sleep deprivation for 6 hr in the latter half
of the night. Compared to the precise excision control
line, 1A mutant flies had significantly reduced sleep
rebound (Figure S3A).
Mapping of the Sleep Phenotype
to the d5-HT1A Locus
To genetically map the phenotype to the lesion in the
d5-HT1A gene, we first carried out deficiency-comple-
mentation tests with a line carrying a deficiency in the
genomic region of d5-HT1A (Df7550) [38]. Flies carrying
the d5-HT1A mutant over the deficiency Df7550 had
a short and fragmented sleep phenotype similar to that
of the d5-HT1A homozygous mutant (data not shown).
We also attempted to rescue the mutant sleep pheno-
type by generating transgenic flies carrying a UAS-
d5-HT1A construct [42]. The transgene was introduced
into the mutant background and expressed under the
control of different drivers. To describe the effect of
transgene expression on the sleep phenotype in mutant
flies, we focused on total sleep and nighttime sleep bout
length and bout number, parameters that were affected
in the female d5-HT1A mutant. When the UAS-d5-HT1A
transgene was expressed panneuronally, driven by an
elav-Gal4 driver, sleep levels and consolidation were
restored in d5-HT1A mutants: total sleep and nighttime
sleep bout length increased while bout number
decreased (Figure S4), suggesting that the lesion in
d5-HT1A was responsible for the sleep phenotype.
To identify specific brain regions important for the
function of d5-HT1A, we first determined its expression
pattern through in situ RNA hybridization. In whole-
mount adult fly brains, the signal from hybridized d5-
HT1A transcripts was observed largely in the mushroom
bodies (Figure 4A). Based on this expression pattern, wesought to determine if the sleep phenotype could be res-
cued through targeted expression of d5-HT1A in adult
mushroom bodies. Therefore, we expressed the UAS
construct under the control of an RU486-inducible
mushroom body Gal4 driver, MB-Switch [43]. d5-HT1A
mutant flies carrying the UAS transgene and the induc-
ible Gal4 driver were subjected to sleep tests, with one
group treated with RU486 (500 mm, 1% ethanol) for
expressing the transgene and another group serving
as control (1% ethanol only). Total daily sleep and night-
time sleep bout length were restored to wild-type levels
in RU486-treated Gal4-driven transgenic animals but
not in uninduced controls (Figure 4B). These results
indicate that the effect on sleep of defective d5-HT1A
signaling can be rescued by restoring expression
of the wild-type gene exclusively in adult mushroom
bodies.
Based upon the high degree of sequence homology
and similar molecular properties reported previously
[22], it is conceivable that d5-HT1A and d5-HT1B act
through similar signaling pathways in distinct brain re-
gions and can substitute for each other when expressed
in a functionally relevant location. However, despite the
similarity, a d5-HT1B transgene expressed in adult
mushroom bodies did not rescue the d5-HT1A mutant
phenotype (Figure 4B). We also tested for possible
genetic interactions between these two receptors by
assaying sleep in flies with reduced levels of both.
Knocking down the expression of d5-HT1B, by the
UAS-1BRNAi transgene, in a 1A heterozygous mutant
background did not produce any baseline sleep pheno-
type (Figure S3B). Together, these data indicate a spe-
cific role for d5-HT1A in fly sleep that is carried out in
adult mushroom bodies.
Elevating Serotonin Levels in Flies Promotes Sleep
One major piece of evidence supporting a sleep-pro-
moting effect of serotonin in mammals is the effect of
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(A) Flies carrying a deletion in the d5-HT1A gene have normal circadian rhythms. Activity records show data averaged from 16 flies. The light-dark
cycles and genotypes are indicated. As compared to the heterozygous sibling controls (1At/+), flies carrying the d5-HT1A deletion (1At/t) had
normal circadian periods and rhythmicity in DD, but showed increased nighttime activity.
(B) Flies carrying the d5-HT1A deletion have reduced baseline sleep and sleep consolidation. Top left: Daily sleep profile of female d5-HT1A mu-
tant flies (1At/t) versus the heterozygous control (1At/+). Top right: Total sleep in the light and dark periods of the day, plotted for three genotypes:
precise excision control (1A+/+) (n = 30), the d5-HT1A mutant (n = 31), and the heterozygous sibling control (n = 31). As compared to both controls,
the d5-HT1A mutant had significantly reduced nighttime sleep. Bottom: Average sleep bout length (left) and sleep bout number (right) during the
light and dark period of the day in female flies. Flies with the d5-HT1A deletion had significantly reduced nighttime sleep bout length and
increased nighttime sleep bout number as compared to both controls.
(C) d5-HT1A mutant flies have reduced sleep and sleep consolidation in constant dark conditions. Female flies were entrained in light-dark cycles
for 3 days and transferred to constant darkness. The bar graphs show percentage changes effected by constant darkness in total sleep amount,
sleep bout length, and sleep bout number. Both precise excision control flies (n = 31) and d5-HT1A mutants (n = 29) responded to the lack of light-
dark cycles with reduced overall sleep, reduced bout length, and increased bout number, but the changes were significantly greater in the
mutant. **p < 0.01, by Student’s t test. Error bars represent SEM.
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notype in d5-HT1A Mutant Flies
(A) The d5-HT1A receptor is expressed in the
adult mushroom body. Whole-mount adult fly
brains were fixed and subjected to in situ hy-
bridization via a biotin-labeled d5-HT1A RNA
probe. Arrows point to the mushroom body
(MB) in the fly brain. The antisense probe de-
tected a clear signal in MBs. The sense probe
served as control. Similar results were seen in
five brain samples.
(B) Rescue of the d5-HT1A mutant phenotype
by expressing the wild-type d5-HT1A gene,
but not the d5-HT1B gene, in the MB of adult
flies. An inducible Gal4 driver, which ex-
presses specifically in the mushroom body
(MB-Switch), was introduced into the d5-
HT1A mutant background. d5-HT1A mutant
flies carrying a single copy of both the MB-
Switch driver and either UAS-d5-HT1A
(UAS-1A) or UAS-d5-HT1B (UAS-1B) were
tested for sleep phenotypes with (RU486+)
or without (RU4862). Mutant flies with only
the MB-Switch transgene (1At/t; MB-Switch,
n = 28 for RU4862; n = 30 for RU486+) and
those expressing UAS-d5-HT1B under the
control of MB-Switch (1At/t; MB-Switch/
UAS-1B, n = 41 for RU4862; n = 43 for
RU486+) had no significant response to the
drug treatment. However, flies in which
UAS-1A expression was driven by RU486-in-
duced MB-Switch (1At/t; MB-Switch/UAS-1A,
n = 44) had significantly increased sleep and
nighttime sleep bout length and reduced
nighttime sleep bout number as compared
to controls that were not treated with RU486
(n = 45). Flies with the MB-Switch transgene
in the precise excision background (1A+/+;
MB-Switch, n = 45 for RU4862; n = 43 for
RU486+) served as controls with wild-type
sleep levels. Although uninduced and in-
duced 1A mutant flies carrying the UAS-1B
trangene showed somewhat increased sleep,
this was not due to leaky expression of the 1B
receptor (data not shown). **p < 0.01, by
Student’s t test. Error bars represent SEM.pharmacological agents that modulate serotonin levels.
When delivered systemically, the serotonin synthesis in-
hibitor parachlorophenylalanine (pCPA) causes insom-
nia, which can be rescued by treatment with the seroto-
nin synthesis precursor 5-hydroxytryptophan (5-HTP)
[15]. Previous reports suggested that systemic adminis-
tration of pCPA does not deplete serotonin in the fly
brain [44]. However, 5-HTP treatment increases seroto-
nin levels in the CNS of both mammals and insects [25,
45]. To test whether increasing serotonin levels affects
fly sleep, we assayed behavioral responses to chronic
treatment with 5-HTP in female wild-type Canton-S flies.
Doses of 5-HTP from 1 mg/ml to 5 mg/ml generated sim-
ilar behavioral responses in Canton-S flies while the
response to lower doses varied from fly to fly. Therefore,a 1 mg/ml dose was used in the following experiments.
As compared to control flies, flies treated with 5-HTP
had significantly increased amounts of sleep
(Figure 5A), which was more pronounced during the
day (Figure 5A). Because daytime sleep tends to be
poorly consolidated, the increased sleep was mani-
fested more as an increase in bout number than bout
length (data not shown). The lack of a significant effect
upon nighttime sleep was most likely due to a ‘‘ceiling’’
effect in light of the fact that Canton-S female flies
have high nighttime sleep. We also observed that 5-
HTP treatment reduced locomotor activity in flies
(Figure 5A). However, these effects of serotonin on fly
locomotion were generally variable and could be disso-
ciated from the effect of serotonin on sleep.
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(A) Baseline sleep is increased in 5-HTP-treated wild-type Canton-S flies. Daily activity (left) and sleep (right) profiles of mock treated (dashed
line) versus 5-HTP-treated (solid line) flies. 5-HTP-treated flies had a mild reduction in their locomotion as measured by the number of beam
crossings per 30 min in a 24 hr period. The sleep profile shows the time spent in sleep every 30 min over a 24 hr period. Flies treated with
5-HTP had more sleep than the mock treated flies; this was more obvious during the daytime, as nighttime sleep levels are almost saturated
in wild-type flies.
(B) The effect of 5-HTP on fly sleep is mediated through elevated extracellular serotonin levels. Flies carrying a UAS-TNTG transgene were
crossed to either a TH-Gal4 or a Ddc-Gal4 driver for blocking chemical neurotransmission in dopaminergic cells only or both dopaminergic
and serotonergic cells, respectively. The progeny and parental controls were tested for the response to 5-HTP treatment. All the 5-HTP-treated
controls and TH-Gal4/UAS-TNT flies had significantly increased sleep compared to their respective untreated controls (**p < 0.01, by Student’s
t test); however,Ddc-Gal4/UAS-TNT flies had no significant response. The brackets on top indicate results of ANOVA for a genotype X drug effect
in two groups of flies. A significant genotype X drug interaction was indicated for the analysis of Ddc neurons (p < 0.05, by Student’s t test), but
not for the TH neurons. Numbers of flies tested for each experimental group wasw30.
(C) Differential response to 5-HTP in known mutants with a short-sleep phenotype. With 5-HTP treatment, daily sleep and nighttime sleep bout
length were increased in cyc01 mutant flies (n = 14 for mock treated, n = 14 for 5-HTP-treated) and in flies carrying a hs-PKA transgene (n = 44 for
mock treated, n = 46 for 5-HTP-treated). A loss-of-function mutant of shaker, minisleep (mns) (n = 29 for mock treated, n = 30 for 5-HTP-treated),
responded to the 5-HTP treatment differently, with an increase in daily sleep and a significant reduction in night time sleep bout length. In Canton-
S flies (cs, n = 31 for mock treated and 5-HTP-treated), daily sleep was significantly increased, but there was no change in nighttime sleep bout
length. **p < 0.01, by Student’s t test. Error bars represent SEM.
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diated through an increase in levels of extracelluar sero-
tonin, we tested the response to 5-HTP in flies in which
chemical neurotransmission was blocked in serotoner-
gic cells. Flies carrying a UAS-TNT (tetanus neurotoxin
light chain) transgene were crossed either to a Ddc-
Gal4 driver, which drives expression in dopamine- and
serotonin-producing cells, or to a TH-Gal4 driver, which
is expressed in dopaminergic cells only. Progeny of
each cross were tested in sleep assays with or without
5-HTP treatment and compared to their parental con-
trols. Although daily sleep amount varied among geno-
types, all parental control lines responded to the
5-HTP treatment with elevated daily sleep. However,
baseline sleep in Ddc-Gal4/UAS-TNT flies did not
change significantly in response to 5-HTP treatment
(Figure 5B). Further statistical analysis that used ANOVA
to test for an interaction between genotype and drug
treatment confirmed that the expression of UAS-TNT
driven by Ddc-Gal4 had a significant effect on the sleep
phenotype produced by 5-HTP (Figure 5B). In contrast,
TH-Gal4/UAS-TNT flies had elevated sleep, which in-
creased further in the 5-HTP-treated group (Figure 5B).
The high baseline sleep phenotype in TH-Gal4/UAS-
TNT flies is consistent with published data on the effect
of the dopamine system in promoting arousal in flies
[8, 46]. At the same time, chemical silencing of the dopa-
minergic cells did not affect the response to 5-HTP treat-
ment, indicating that the lack of a response to 5-HTP in
Ddc-Gal4/UAS-TNT flies is due to the loss of serotoner-
gic transmission.
We next determined whether this effect of 5-HTP was
universal across fly lines, in particular in lines with short-
sleep phenotypes. All control strains tested, including
yw, w1118, and Oregon-R, showed increased sleep in
response to 5-HTP treatment (data not shown). Interest-
ingly, d5-HT1A mutants also exhibited a significant
increase in sleep after treatment with 5-HTP (Fig-
ure S5A), suggesting that increased serotonin levels
may compensate for the deficit in d5-HT1A signaling,
possibly through activating other unidentified serotonin
receptors. Of the short-sleep mutants we tested, flies
carrying a loss-of-function mutation in a clock gene
(cycle) or expressing a constitutively active protein ki-
nase A molecule under the control of a leaky heat-shock
promoter [6, 47] showed increased sleep in response to
5-HTP treatment. Since the mutants had decreased
sleep at all times, sleep-promoting effects of 5-HTP
were visible at night as well as during the day and, in
fact, even increased nighttime sleep bout duration was
observed (Figure 5C). However, effects on nighttime
sleep bout number were different in the two genotypes
(Figure S5B). Short-sleep flies mutant for a potassium
channel (Shaker) [7, 8] slept more in response to 5-
HTP, but did not show increased bout duration at night.
As a matter of fact, the Shaker flies showed reduced
consolidation at night by both measures, but particularly
in the greatly increased sleep bout number (Figure 5C,
Figure S5B). Together, these data suggest that elevated
serotonin can counteract the effects of other molecules
that affect sleep, although to varying extents. We spec-
ulate that the differences in the response of the mutants
arise from differences in the mechanism of action of
each of the respective mutations.To further investigate the effect of elevated serotonin
on fly sleep, we generated transgenic flies with in-
creased serotonin production. This was achieved by
overexpressing an enzyme, tryptophan hydroxylase
(TPH), which is responsible for catalyzing the conversion
of tryptophan to 5-hydroxytryptamine, the first and the
rate-limiting step in serotonin synthesis [44]. As in
the mammalian system, there are two TPH isoforms
in the Drosophila genome, DTPH (henna) and DTRH
(CG9122) [44, 48, 49]. The expression pattern of these
two genes, as determined by in situ hybridization at
a late embryonic stage, indicated that DTPH is ex-
pressed in the fat body, while DTRH is expressed in
the central nervous system (BDGP in situ). Thus, DTRH
is most likely the TPH isoform that is important for sero-
tonin production in the Drosophila CNS.
Overexpression of DTRH was driven by Ddc-Gal4 in
serotonergic and dopaminergic cells, and the effect on
serotonin levels was confirmed by ELISA assays of fly
head extracts (Figure 6A). Female flies with elevated
serotonin levels were subjected to sleep analysis. As
compared to control flies, Ddc-Gal4/UAS-DTRH flies
had significantly increased total sleep and night sleep
bout length, as well as reduced sleep bout number
(Figure 6B). Therefore, elevating serotonin levels
through both pharmacological and genetic approaches
enhances fly sleep.
Discussion
In this report, we utilized Drosophila as a model system
to study the function of serotonin in sleep. The genetic
tools available in Drosophila allowed us to study loss-
of-function mutants of three serotonin receptors:
d5-HT1A, d5-HT1B, and d5-HT2. A significant effect on
sleep was observed in flies with a truncated d5-HT1A re-
ceptor. These flies had short and fragmented sleep,
which was rescued by expressing a d5-HT1A transgene
in adult mushroom bodies. Pharmacological studies
with a serotonin synthesis precursor achieved a similar
effect in flies as in mammals, which is to promote sleep.
Our studies provide evidence for serotonergic signaling
in the regulation of Drosophila sleep, identify a receptor
that specifically functions in this process, and suggest
that two serotonin receptor subtypes, d5-HT1A and
d5-HT1B, mediate effects of serotonin on different be-
haviors in distinct regions of the brain.
The lesion in the d5-HT1A mutant also affects the
neighboring gene CG15117, which codes for a protein
of unknown function, possibly involved in carbohydrate
metabolism. Since the sleep phenotype was rescued by
expression of d5-HT1A alone, we believe that the sleep
abnormality of the mutant was caused solely by the dis-
ruption of d5-HT1A and not the neighboring gene. While
our data are definitive with respect to a role for d5-HT1A
in sleep, we acknowledge that at this point we can not
completely exclude a role for d5-HT1B and d5-HT2.
The loss-of-function mutants we tested for these recep-
tors are still capable of producing small amounts of tran-
script, although, at least in the d5-HT1B mutant, this
transcript expression is too low to conduct its circadian
function [27]. In addition, based on the sleep-enhancing
effect of 5-HTP treatment in d5-HT1A mutant flies, we
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(A) Increased serotonin levels in flies overexpressing DTRH. Two in-
dependent insertion lines for UAS-DTRH transgene (UAS-DTRHa
and UAS-DTRHb) were crossed to Ddc-Gal4 for expression in sero-
tonergic and dopaminergic cells. Fly heads were collected from in-
dicated genotypes and subjected to quantitative immunoassays
for serotonin content. As compared to controls, Ddc-Gal4/UAS-
TRH flies had significantly increased serotonin levels in head ex-
tracts. **p < 0.01, by Student’s t test. Error bars represent standard
deviation.
(B) Flies with genetically elevated serotonin levels have increased to-
tal sleep and sleep consolidation. Flies expressing DTRH driven by
Ddc-Gal4 had significantly increased nighttime sleep bout length
and total sleep and reduced nighttime sleep bout number, as com-
pared to parental controls. Number of flies tested for each experi-
mental group wasw16. **p < 0.01, *p < 0.05, by Student’s t test. Error
bars represent SEM.believe other unidentified serotonin receptors function
in sleep regulation.
Although they showed no obvious defects, homozy-
gous flies carrying the truncated d5-HT1A receptor
were less viable than flies with a single copy of the
mutation in the same background. When maintained
as heterozygotes, less than 5% of the progeny were ho-
mozygous for the d5-HT1A mutation. In homozygous
stocks, the short-sleep phenotype weakened, such
that sleep increased after several generations. This is
consistent with the notion that the sleep phenotype is
highly modifiable, especially when it is associated with
reduced viability. A similar situation was reported for
the Shaker mutants where the short-sleep phenotype
diminished significantly within some generations in
a w1118 background [7]. For analysis of the d5-HT1A
mutant, we avoided this problem by constantly main-
taining a heterozygous stock and by employing a homo-
zygous stock for no more than the first two generations.
We note, however, that the d5-HT1A mutation was intro-
duced into backgrounds containing different UAS or
Gal4 transgenes for the rescue experiment, and it con-
sistently maintained its phenotype. Thus, the effects of
modifiers/background do not constitute an insurmount-
able problem in the analysis of sleep mutants.
We speculate that serotonin has a conserved function
in sleep regulation. In mammals, systemic administra-
tion of 5-HTP or of an agonist of the mammalian
5-HT1A receptor increases slow-wave sleep (SWS)
and reduces sleep latency [13, 14]. However, analysis
of the mammalian 5-HT1A receptor has been compli-
cated, in part because of the difficulty of dissociating
its pre- and postsynaptic actions and also because of
compensatory effects involving upregulation of other re-
ceptor subtypes [13, 14, 16–18]. This may account for
the lack of a NREM or total sleep phenotype in the
5-HT1A knockout mice [17]. We identified a sleep phe-
notype in the Drosophila 5-HT1A mutant and demon-
strate an additional role for this receptor in the mainte-
nance of sleep stability. The phenotype in Drosophila,
we believe, results from the simpler structure of the fly
genome with its less compensated serotonergic sys-
tem. Also, while sleep in rodents is quite fragmented,
flies, like humans, have prolonged sleep episodes.
This may facilitate the identification of sleep-consolidat-
ing factors such as d5-HT1A.
Associating the effect of serotonin on sleep with a spe-
cific receptor subtype provides a means to dissect the
underlying circuitry and signaling pathways. Through
genetic rescue experiments, we find that d5-HT1A is re-
quired in the mushroom bodies to promote sleep stabil-
ity. Our previous studies demonstrated a role for
d5-HT1B in circadian entrainment in clock cells and
showed that this receptor is also expressed in the mush-
room bodies. However, d5-HT1B could not substitute
for the function of d5-HT1A in fly sleep in rescue exper-
iments, suggesting that, in addition to tissue-specific
regulation, different downstream signaling is involved
in fly behaviors modulated by serotonin. Although the
two receptors share more than 80% homology in overall
protein sequence, their N termini and third intracellular
loops are very different, which could account for their
molecular differences. In addition, it is possible that
the expression of 1A and 1B in mushroom bodies is
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servations demonstrate that it is possible to link the reg-
ulatory effect of serotonin on complex behaviors in
Drosophilawith distinct receptor types and with specific
neuronal structures.
The localization of d5-HT1A action to the adult mush-
room bodies is consistent with recent studies that indi-
cate a sleep-regulating role for mushroom bodies [31].
The mushroom body is an important neuronal structure
for control of locomotion and integration of sensory in-
puts, as well as learning and memory in flies [43, 50,
51]. This study supports the association between sleep
and memory consolidation. It is also consistent with the
role of serotonin in learning and memory [34].
A link between serotonin and human sleep has been
demonstrated in clinical studies. Pathological condi-
tions associated with serotonin deficits are linked to re-
duced sleep amount and quality. For instance, patients
with clinical depression usually have sleep disorders
[52, 53]. Antidepressant treatment upregulating seroto-
nergic signaling improves their mental condition as
well as their sleep quality [54]. Results of our studies
that used pharmacological and genetic approaches
suggest that serotonin also promotes sleep in flies. In
addition, our studies support the complementary con-
clusion, that is, flies with defects in serotonin signaling
sleep less. Together, our results provide a model for
studying the underlying mechanism and neuronal struc-
tures involved in the effect of serotonin on sleep.
Conclusions
We show here that serotonin and the d5-HT1A receptor
promote sleep in Drosophila. Serotonin can even in-
crease sleep and sleep consolidation in some short-
sleep mutants, suggesting that it has a central role in
the control of sleep. The finding that d5-HT1A acts in
the adult mushroom bodies to regulate sleep links sleep
and serotonin signaling to learning and memory. Finally,
given that effects of serotonin on circadian rhythms are
mediated by the d5-HT1B receptor, and not by d5-
HT1A, these data indicate nonoverlapping roles for
serotonin receptor subtypes in the circadian and
homeostatic control of sleep.
Experimental Procedures
Fly Strains and Transgenes
UAS-d5-HT1A and UAS-DTRH (CG9122) transgenic flies were gen-
erated as described [55]. Dr. Julian Dow of University of Glasgow
provided the transgene construct for UAS-d5-HT1A [42]. The
cDNA template for generating the UAS-DTRH transgene was
obtained from the DGRC cDNA collection (GH12537). Multiple trans-
formed lines were mapped and balanced in a w2 background. Two
independent insertion lines were tested in the behavioral analysis
and yielded similar results. Flies carrying UAS-d5-HT1B, UAS-
d5-HT1BRNAi, d5-HT1B-Gal4, tim-Gal4, elav-Gal4, and Ddc-Gal4
were as described [27]. Dr. Serge Berman provided TH-Gal4, Dr.
Ron Davis provided MB-Switch, and Dr. Chiara Cirelli provided
mns flies in CS background. Other fly lines were obtained from the
Bloomington stock center (Stock number/name: e01363/5HT2RB,
17629/EY09988, 7550/Df7550, 6326/w1118).
Behavioral Analysis
For circadian analysis, flies were entrained to 12:12 light-dark (LD)
cycles at 25ºC. 3- to 7-day-old flies were used in the behavioral ana-
lysis. Locomotor activity of individual flies was monitored in LD fol-
lowed by constant darkness (DD) conditions as previouslydescribed [55]. Activity records were analyzed with Clocklab soft-
ware (Actimetrics).
For sleep analysis, 7- to 10-day-old flies were monitored in light-
dark conditions at 25ºC. Locomotor activity of individual flies was
monitored and collected with the DAM systems as previously de-
scribed [30]. Generally, flies subjected to certain conditions (such
as different light:dark conditions or pharmacological treatments)
were given a day for adaptation, and data from the second and the
third day of the recording were used for analysis. Locomotor activity
was collected in 1 min bins and analyzed with a MATLAB-based
software written in-house. The total sleep, the average length of
sleep bouts, and the number of sleep bouts were calculated based
on the sleep definition as a period of 5 or more minutes of behavioral
immobility.
Generating d5-HT1A Mutant through Imprecise Excision
of a P Element
The fly line, P[EPgy2]EY09988, carrying a P element insertion near
the C-terminal end of the d5-HT1A transcript (w2.5 kb downstream
of the stop codon of the coding region) was obtained from the Bloo-
mington stock center (stock number 17629) [39]. Mobilization and
excision of the P element were as described [56].w500 independent
excision lines were screened by genomic PCR via primers specific
for the eighth exon of d5-HT1A. The imprecise excision line and
three precise excision lines were maintained over a second chromo-
some balancer with the GFP marker (CyO, P[ActGFP]JMR1).
Pharmacological Treatment of Flies
5-HTP and RU486 were obtained from Sigma. For sleep assays, flies
were maintained on food containing 1 mg/ml 5-HTP or 500 mm
RU486 (treated group) or regular food (mock treated group) for 4
days. Behavioral data from the second and third day were used for
analysis.
In Situ RNA Hybridization
Adult fly brains were dissected and fixed in 4% parafomaldehyde/
PBS with 0.05% Tween 20 at 4ºC overnight. The tissues were then
dehydrated and rehydrated through a methanol gradient (25%,
50%, 75%, 100%), followed by protease K (Roche,w19 mg/ml) di-
gestion for 10 min at room temperature. After the second fixation
(4% PFA/PBS, 0.05% Tween 20, room temperature for 20 min) and
prehybridization (50% fomamide, 53SSC, 53 denhardts solution,
250 mg/ml tRNA, 500 mg/ml ssDNA, 50 mg/ml Heparin, 2.5 mM
EDTA, 0.1% Tween 20, at 58ºC for overnight), the tissues were incu-
bated with hybridization solution including probes (w25 ng/ml) at
58ºC for 48 hr. The antisense and sense RNA probes for d5-HT1A
(nucleotides 370–726) were synthesized and labeled with a biotin
RNA labeling kit (Roche). Signals from hybridized RNA were de-
tected with the Tetramethylrhodamine-conjugated tyramide (Perkin-
Elmer). Brains were imaged with a confocal microscope (Leica) and
processed with Open-lab and Adobe Photoshop software.
Expression Constructs, Transfection, and Pharmocological
Treatments in S2 Cells
Cloning and expression of the full-length and truncated d5-HT1A in
the S2 cell culture system were as described [27]. The coding region
of d5-HT1A was amplified with the UAS-d5-HT1A construct as tem-
plate and cloned into pIZ/His-V5 (Invitrogen) [57]. A V5 epitope was
tagged to the carboxyl terminus of the receptor. For the receptor in-
ternalization assay, S2 cells stably expressing d5-HT1A-V5 were
seeded on glass cover slips and serum starved overnight. After
treatment with 100 nM serotonin for 30 min, the cover slips were
washed with PBS and fixed in 4% PFA/PBS followed by immunos-
taining with an anti-V5 antibody. The cells were analyzed with a con-
focal microscope (Leica). The images were processed with Open-
lab and Adobe Photoshop software.
Quantitative Immunoassay for Serotonin Levels in Fly Heads
For each sample,w25 fly heads were homogenized and subjected
to acetylation, followed immediately by immunoassay with a seroto-
nin EIA kit as described by the manufacturer (ALPCO). The results
were calculated based on a standard curve.
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